Navigation Links
Cation Exchange ProteinChip Arrays from Ciphergen

ProductsCation Exchange ProteinChip Arrays from Ciphergen
Company Ciphergen
Item Cation Exchange ProteinChip Arrays
Price 
Description Ciphergen's ProteinChip arrays have been developed for affinity capture of proteins from biological samples. A variety of ProteinChip chemical surfaces allow differential capture of proteins according to their unique biochemical properties. Each chip has eight different spots, allowing side-by-side sample comparison, and the chips are color-coded with a unique hydrophobic coating. Ciphergen's proprietary chip technology thus allows the researcher to rapidly capture, purify and characterize proteins directly on the chip.
Cationic arrays bind proteins through electrostatic interaction of positively charged amino acids such as lysine, arginine and histidine. Binding occurs at low pH with low salt; binding decreases as pH and salt concentration increase.
ProteinChip WCX2: is a weak cation exchange array with a carboxylate surface to bind cationic proteins. The negatively charged carboxylate groups on the surface of the WCX2 chip interact with the positive charges exposed on the target proteins. The binding of the target proteins is reduced by increasing the concentration of salt or by increasing the pH of the washing buffers.
Info CiphergenCiphergen
Ciphergen Biosystems, Inc
6611 Dumbarton Circle
Fremont, CA 94555

Customer Service: 510-505-2188
Fax Number: (510) 505-2101
Web Site: http://www.ciphergen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Anion Exchange ProteinChip Arrays from Ciphergen
2. Anti-Na+ / H+ Exchanger-1, isoform NHE1 Monoclonal Antibody, Unconjugated from CHEMICON
3. T4 Polynucleotide Kinase Exchange Reaction Buffer from Invitrogen
4. ProteinChip beta-amyloid multipeptide detection Kit from Ciphergen
5. ProteinChip Antibody Capture Kit from Ciphergen
6. Immobilized Metal affinity ProteinChip Arrays from Ciphergen
7. Hydrophilic ProteinChip Arrays from Ciphergen
8. Hydrophobic ProteinChip Arrays from Ciphergen
9. ProteinChip System, Series 4000 from Ciphergen
10. PS20 and RS100 preactivated ProteinChip Arrays from Ciphergen
11. Multi - Organ Tissue - Arrays from Dominion Pharmakine S.L.
(Date:1/6/2017)... -- Delta ID Inc., a leader in consumer-grade iris scanning ... CES® 2017. Delta ID has collaborated with Gentex Corporation ... of iris scanning as a secure, reliable and convenient ... car, and as a way to elevate the security ... ID and Gentex will demonstrate (booth #7326 LVCC) a ...
(Date:1/3/2017)... LAS VEGAS , Jan. 3, 2017 ... announced the introduction of Onitor Track, an innovative biometric ... and men, showcasing this month at the 2017 Consumer ... . In the U.S., the World ... affect more than two-thirds of adults who are overweight ...
(Date:12/20/2016)... , Dec. 20, 2016 The ... sharing, rental and leasing is stoking significant interest ... radio frequency technology, Bluetooth low energy (BLE), biometrics ... as the next wave of wireless technologies in ... access system to advanced access systems opens the ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... ... January 12, 2017 , ... Each year, Crain’s Detroit Business News ranks the ... evaluates the patent estate of a company, its impact and significance, and the likelihood ... the way in technologies that transform energy sources such as low dose X-ray and ...
(Date:1/12/2017)... ... January 12, 2017 , ... After ... Lisa Rosendahl’s doctors gave her only a few months to live. Now a ... that has stabilized Rosendahl’s disease and increased both the quantity and quality of ...
(Date:1/12/2017)... and Pune, India , January 12, 2017 ... Toxicity Testing Market by Type and End Users - Global Opportunity Analysis and Industry ... million by 2022 from $2,921 million in 2015, growing at a CAGR of 15.07% ... ... Allied Market Research Logo ...
(Date:1/11/2017)... Colo. (PRWEB) , ... January 11, 2017 , ... ... the journal Clinical Cancer Research show early promise of the investigational anti-cancer agent ... despite a median 5 previous treatment regimens. Twenty-seven percent of these heavily pretreated ...
Breaking Biology Technology: